Drugs that may increase the risk of hypoglycemia : antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors Drugs that may decrease the blood glucose lowering effect: atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones Drugs that may increase or decrease the blood glucose lowering effect : alcohol, beta-blockers, clonidine, lithium salts, and pentamidine Drugs that may blunt the signs and symptoms of hypoglycemia : beta-blockers, clonidine, guanethidine, and reserpine Please click here for Tresiba Prescribing Information
USA peptide manufacturer
Report the Website File complaints with your local consumer protection agency or online fraud centers: FTC.gov (U.S.) IC3.gov (for international online scams) Your countrys consumer protection bureau Include screenshots and the full web address in your report
J.PapiA.SinghD.AnzuetoA.MartinezF
10.1016/s0891-5849(96)00526-6 10.1016/s0891-5849(96)00526-6 [DOI] [PubMed] [Google Scholar] Wei PC, Hsieh YH, Su MI (2012a) Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease
